We review here the current experimental evidence suggesting that activation of the ACE2/Ang-(1–9) pathway protects the heart and vessels (and possibly the kidney) from adverse cardiovascular remodeling in hypertension as well as in heart failure. The gene discussed is ACE2; the disease is Hypertension.